Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2026 · 10-Q
Revenue—
Net Income-$2.26M-$2.26MN/M vs Q1 2025 EPS Diluted-$0.21-$0.21N/M vs Q1 2025 Operating Income-$2,266,000N/M Operating Cash Flow-$1,659,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,662,000N/M ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end